WallStreetZenWallStreetZen

NASDAQ: PTGX
Protagonist Therapeutics Inc Stock Ownership - Who owns Protagonist Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protagonist Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arturo Md MolinaChief Medical Officer2025-06-1010,000$8.04
$80.40kBuy
Arturo Md MolinaChief Medical Officer2025-06-1010,000$57.03
$570.30kSell
Arturo Md MolinaChief Medical Officer2025-06-0910,000$8.04
$80.40kBuy
Arturo Md MolinaChief Medical Officer2025-06-0910,000$55.51
$555.10kSell
Harold E. SelickDirector2025-04-2810,725$1.16
$12.44kBuy
Asif AliChief Financial Officer2025-04-221,756$46.00
$80.78kSell
William D. WaddillDirector2025-03-174,000$54.25
$217.00kSell
Arturo Md MolinaChief Medical Officer2025-03-132,077$38.98
$80.96kBuy
Arturo Md MolinaChief Medical Officer2025-03-1330,514$55.74
$1.70MSell
Arturo Md MolinaChief Medical Officer2025-03-1328,437$23.42
$665.99kBuy

1 of 4

PTGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTGX insiders and whales buy or sell their stock.

PTGX Shareholders

What type of owners hold Protagonist Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.71%9,736,767$548.86MInstitution
Farallon Capital Management LLC9.85%6,107,006$344.25MInstitution
Rtw Investments LP9.23%5,719,415$322.40MInstitution
Vanguard Group Inc6.90%4,277,218$241.11MInstitution
Deep Track Capital LP4.84%3,000,000$169.11MInstitution
State Street Corp4.37%2,706,619$152.57MInstitution
Bvf Inc4.15%2,575,015$145.15MInstitution
Julie Papanek3.96%2,453,255$138.29MInsider
Johnson Johnson3.95%2,449,183$138.06MInsider
Johnson Johnson3.95%2,449,183$138.06MInstitution

1 of 3

PTGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTGX81.70%18.30%Net BuyingNet Buying
SWTX63.25%36.75%Net Selling
RARE84.71%15.29%Net SellingNet Selling
SRPT75.07%24.93%Net SellingNet Buying
CRSP65.79%34.21%Net SellingNet Selling
View Top Biotech Stocks

Protagonist Therapeutics Stock Ownership FAQ

Who owns Protagonist Therapeutics?

Protagonist Therapeutics (NASDAQ: PTGX) is owned by 105.31% institutional shareholders, 23.59% Protagonist Therapeutics insiders, and 0.00% retail investors. Julie Papanek is the largest individual Protagonist Therapeutics shareholder, owning 2.45M shares representing 3.96% of the company. Julie Papanek's Protagonist Therapeutics shares are currently valued at $138.29M.

If you're new to stock investing, here's how to buy Protagonist Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.